Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1944 participants.

Also called NCT07611747

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 1,944 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07611747
  • EU CT 2025-521086-28-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07611747. Randomized; no masking; primary purpose prevention. Start 2026-04-22 (actual); primary completion 2031-04-22 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Acronym
PREVENER
Condition
Rheumatoid Arthritis (RA)
Condition
Psoriatic Arthritis (PsA)
Condition
Systemic Lupus Erythematosus (SLE)
Condition
Carotid Artery Diseases
Condition
Cardio Vascular Disease
Condition
Atheroscleroses
Condition
Axial Spondyloarthritis
Intervention (Diagnostic test)
Carotid Ultrasound
Intervention (Drug)
High-intensity lipid-lowering therapy
Intervention (Other)
Standard care according to ESC 2021 guidelines
Lead sponsor
Instituto de Investigación Marqués de Valdecilla (class: other)

Record details

Record id
cardio:ct-nct07611747
Content hash
4720c44743f7fd8646162f86394779c995a62d594348bd1ba54920e149c95503